EGFR mutations are more common in adenocarcinoma than in squamous carcinoma, and 51.4% of advanced lung adenocarcinoma patients in Asia have this mutation [18, 19]; the EGFR variation frequency is higher in women and nonsmoking patients [20, 21]. This evidence concerns the gene EGFR and lung adenocarcinoma.